Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2014
10/21/2014US8865738 5-membered heterocyclic compound cyclopenta[C]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
10/21/2014US8865734 Anti-infective compounds
10/21/2014US8865727 Method for treating pain syndrome and other disorders
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865717 Heterocyclic compounds
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865703 Pyridyltriazoles
10/21/2014US8865702 B1-antagonists
10/21/2014US8865323 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
10/21/2014US8865321 Organic electroluminescent devices
10/16/2014US20140309262 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
10/16/2014US20140309259 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309257 Topoisomerase inhibitors and methods of making and use as therapeutic agents
10/16/2014US20140309255 Compounds and methods for treatment of systemic lupus erythematosus
10/16/2014US20140309253 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde 10a)
10/16/2014US20140309249 Inhibitors of c-jun-n-terminal kinase (jnk)
10/16/2014US20140309248 Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
10/16/2014US20140309245 Novel Heterocyclic Carboxamides as Modulators of Kinase Activity
10/16/2014US20140309240 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309237 Compounds that modulate intracellular calcium
10/16/2014US20140309234 Small molecule anti-fibrotic compounds and uses thereof
10/16/2014US20140309231 Nitrogen-containing heterocyclic compounds
10/16/2014US20140309228 Quaternized amines as sodium channel blockers
10/16/2014US20140309227 QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
10/16/2014US20140309226 Piperidinyl-substituted cyclic ureas as gpr119 modulators
10/16/2014US20140309225 Novel nicotinamide derivative or salt thereof
10/16/2014US20140309221 Method of inhibiting hamartoma tumor cells
10/16/2014US20140309212 Bruton's tyrosine kinase inhibitors
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309193 Novel pyrrole derivatives
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140309109 N-Thio-anthranilamide compounds and their use as pesticides
10/16/2014US20140308282 Pharmaceutical compounds
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859780 Benzimidazole derivatives as selective blockers of persistent sodium current
10/14/2014US8859776 Substituted piperidines that increase p53 activity and the uses thereof
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859767 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
10/14/2014US8859608 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
10/14/2014US8859602 Inhibitors of c-fms kinase
10/14/2014US8859595 Potent and selective inhibitors of hepatitis C virus
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
10/14/2014US8859586 Cyclohexyl isoquinolinone compounds
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859577 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
10/14/2014US8859575 Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859573 Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
10/14/2014US8859571 Quinazoline compounds
10/14/2014US8859570 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
10/14/2014US8859559 Substituted pyrazines and their use in the treatment of disease
10/14/2014US8859557 Substituted oxindole derivatives and their use as vasopressin receptor ligands
10/14/2014US8859556 TRPA1 receptor antagonist
10/14/2014US8859547 Pyridazinone derivatives
10/14/2014US8859546 Picolinamide inhibitors of kinases
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859535 Hydroxy substituted isoquinolinone derivatives
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859109 Compound for organic electroluminescent device and organic electroluminescent device using the same
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014165128A2 Hepatitis b antiviral agents
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014165065A1 Substituted piperidine compounds and their use as orexin receptor modulators
10/09/2014WO2014164756A1 Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
10/09/2014WO2014164558A1 Pyridinyl and fused pyridinyl triazolone derivatives
10/09/2014WO2014163210A1 [11 c] and [18f] labeled 1,3-diphenyl-5-(pyrimidin-2-yl)-pyridin-2(1 h)-one derivatives and their use for pet imaging of the ampa receptor
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014162121A1 Kinase inhibitors based upon n-alkyl pyrazoles
10/09/2014WO2014162039A1 Protein kinase inhibitors
10/09/2014US20140303378 Process for producing pyrrole compound
10/09/2014US20140303207 Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
10/09/2014US20140303206 3-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303182 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/09/2014US20140303174 Pyridazine derivatives as EAAT2 Activators
10/09/2014US20140303168 Phthalazines as potassium ion channel inhibitors
10/09/2014US20140303167 Cdk9 inhibitors in the treatment of midline carcinoma
10/09/2014US20140303164 Therapeutic compounds
10/09/2014US20140303156 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303151 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
10/09/2014US20140303150 Ingenol-3-acylates iii and ingenol-3-carbamates
10/09/2014US20140303139 Pyrimidines as sodium channel blockers
10/09/2014US20140303138 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
10/09/2014US20140303137 Aminopyrimidines useful as kinase inhibitors
10/09/2014US20140302010 Substituted benzimidazoles
10/09/2014US20140301999 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
10/08/2014EP2785709A1 Aminopyrimidine derivatives as lrrk2 modulators
10/08/2014EP2785708A1 Insecticidal triazinone derivatives
10/08/2014EP2785707A1 Novel 2h-indazoles as ep2 receptor antagonists
10/08/2014EP2785706A1 Substituted 4 - phenyl - pyridines for the treatment of nk-1 receptor related diseases
10/08/2014EP2785705A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 1080